Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Pall inaugurates new Singapore Life Sciences Centre of Excellence

Pall Corporation, a global leader in filtration, separation and purification, today inaugurated its Pall Life Sciences Centre of Excellence in Singapore, the latest addition to the company's global customer support network.

From Pall Corporation 8 Sep 2011

Ardea Biosciences reports positive outcome from lesinurad End-of-Phase 2 meetings with FDA

Ardea Biosciences, Inc. announced that it has completed formal End-of-Phase 2 meetings with the U.S. Food and Drug Administration (FDA) and successfully reached agreement on the following key aspects of its proposed lesinurad Phase 3 development plan: the overall size and design of the planned Phase 3 clinical studies, the primary endpoints, the total safety database proposed for NDA filing, manufacturing plans for both drug substance and drug product, the preclinical toxicology program and the clinical pharmacology program.

7 Sep 2011

BARDA awards GlaxoSmithKline contract for development of dual-purpose broad spectrum antibiotic

The federal government today issued a contract for advanced research and development of a dual-purpose broad spectrum antibiotic with potential to treat illnesses caused by bioterrorism threats such as plague and tularemia, as well as more certain life-threatening infections, known as Gram-negative infections, associated with prolonged hospitalization.

7 Sep 2011

Drugs produced in offshore manufacturing plants more likely to have quality problems

Drugs produced in offshore manufacturing plants -- even those run by U.S. manufacturers -- pose a greater quality risk than those prepared in the mainland United States, a new study suggests.

7 Sep 2011

Viewpoints: Analyzing Texas' health insurance record; advice for 'super' committee; one doc's cancer experience

Targeting waste, fraud and abuse; eliminating unnecessary and duplicative spending; and ending military adventurism need not be accompanied by slashing essential services such as education and shredding our social safety nets -; Social Security, Medicare and Medicaid.

7 Sep 2011

AMT, NIH enter exclusive license agreement for use of AAV5-based gene therapy vectors

Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today announced that it has entered into an exclusive license agreement with the US National Institutes of Health (NIH) for use of adeno-associated virus serotype 5 (AAV5)-based gene therapy vectors for liver and brain indications.

6 Sep 2011

Lilly, QIAGEN partner to develop and commercialize companion diagnostic for JAK2 V617F

QIAGEN today announced that it has entered into a partnership with Eli Lilly and Company for the development, manufacturing and commercialization of a molecular companion diagnostic for an early stage investigational compound currently being developed by Lilly. Financial terms of the agreement were not disclosed.

From QIAGEN Manchester Limited 6 Sep 2011

Western, Midwestern states register higher methamphetamine usage

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today issued its annual report on U.S. worker drug use, the Quest Diagnostics Drug Testing Index.

From Quest Diagnostics 2 Sep 2011

Microvisk introduces unique handheld device which monitors blood clotting status

Microvisk Technologies has introduced its unique handheld devices which monitor the blood clotting status of patients to the US market. Showcased at the prestigious American Association for Clinical Chemistry annual conference, the Microvisk devices attracted strong interest from distributors and potential partners ahead of clinical trials in major US medical centres this autumn and product launches in 2012.

31 Aug 2011

New research advances field of plastic-based flexible electronics

New research from Wake Forest University has advanced the field of plastic-based flexible electronics by developing, for the first time, an extremely large molecule that is stable, possesses excellent electrical properties, and inexpensive to produce.

30 Aug 2011

BioAmber selects Sarnia as location for first North American biosuccinic acid plant

BioAmber Inc., through its subsidiary Bluewater Biochemicals has selected Sarnia, Ontario, Canada as the location for its first North American biosuccinic acid plant. The Sarnia plant will have an initial capacity of 17,000 MT and will be commissioned in 2013. Permitting work for the plant was initiated in June 2011. BioAmber currently produces and sells biobased succinic acid at a 3,000 MT capacity plant in France.

29 Aug 2011

SQI Diagnostics third quarter net loss increases to $2,691,000

SQI Diagnostics Inc., a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the third quarter ended June 30, 2011.

29 Aug 2011

Neurotechnology's SentiSight 3.0 SDK now available for universal object recognition

Neurotechnology, a provider of high-precision biometric and object identification technologies, today announced the availability of SentiSight 3.0, a Software Development Kit (SDK) for universal object recognition.

29 Aug 2011

CIRM approves stem cell research planning grants for five UC Davis teams

The California Institute for Regenerative Medicine (CIRM), the state stem cell agency, today approved research planning grants for five UC Davis Health System teams that are working to develop human clinical trials to treat illnesses such as Huntington's disease, vascular disease, osteoporosis, HIV/AIDS and airway disease in children.

29 Aug 2011

NeoStem featured on CBS's Eye on New York City

NeoStem, Inc., an international biopharmaceutical company with a focus on cell-based therapeutic development, today announced that the Company was featured on CBS's Eye on New York City on Wednesday evening, August 24, 2011.

26 Aug 2011

European Journal of Heart Failure publishes results of BIOTRONIK Home-CARE clinical study

BIOTRONIK SE & Co. KG, a worldwide leader in manufacturing cardiac medical devices and pioneer of remote patient management solutions, announced today that results of the Home-CARE (Home Monitoring in Cardiac Resynchronization Therapy) clinical study were published in the European Journal of Heart Failure.

26 Aug 2011

Simcere receives Chinese SFDA approval for Iremod to treat active rheumatoid arthritis

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that it has received the new drug approval from the State Food and Drug Administration for Iremod.

25 Aug 2011

Foreign drug manufacturing, testing raise regulatory and ethical concerns

JAMA discusses "a recent report from the Pew Health Group about the growing risks of substandard and counterfeit medications resulting from the increasing overseas production of pharmaceuticals and their ingredients."

25 Aug 2011

AMT total net loss decreases 7% to € 8.7 million for first half year of 2011

Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today reported its results for the first half year of 2011.

25 Aug 2011

Kewaunee Scientific first quarter sales up 5.9% to $26,321,000

Kewaunee Scientific Corporation today reported sales and earnings for its first quarter ended July 31, 2011. Sales for the quarter were $26,321,000, up 5.9% from sales of $24,858,000 in the first quarter last year. Net earnings for the quarter were $22,000, or $0.01 per diluted share, down from net earnings of $657,000, or $0.25 per diluted share, in the first quarter of the prior year.

24 Aug 2011

Manufacturing News and Research

Further Reading

Pall inaugurates new Singapore Life Sciences Centre of Excellence

Ardea Biosciences reports positive outcome from lesinurad End-of-Phase 2 meetings with FDA

BARDA awards GlaxoSmithKline contract for development of dual-purpose broad spectrum antibiotic

Drugs produced in offshore manufacturing plants more likely to have quality problems

Viewpoints: Analyzing Texas' health insurance record; advice for 'super' committee; one doc's cancer experience

AMT, NIH enter exclusive license agreement for use of AAV5-based gene therapy vectors

Lilly, QIAGEN partner to develop and commercialize companion diagnostic for JAK2 V617F

Western, Midwestern states register higher methamphetamine usage

Microvisk introduces unique handheld device which monitors blood clotting status

New research advances field of plastic-based flexible electronics

BioAmber selects Sarnia as location for first North American biosuccinic acid plant

SQI Diagnostics third quarter net loss increases to $2,691,000

Neurotechnology's SentiSight 3.0 SDK now available for universal object recognition

CIRM approves stem cell research planning grants for five UC Davis teams

NeoStem featured on CBS's Eye on New York City

European Journal of Heart Failure publishes results of BIOTRONIK Home-CARE clinical study

Simcere receives Chinese SFDA approval for Iremod to treat active rheumatoid arthritis

Foreign drug manufacturing, testing raise regulatory and ethical concerns

AMT total net loss decreases 7% to € 8.7 million for first half year of 2011

Kewaunee Scientific first quarter sales up 5.9% to $26,321,000

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest Life Science News